{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:19:37Z","timestamp":1777468777245,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Podocalyxin is a cell surface sialomucin, which is expressed in not only glomerular podocytes but also vascular endothelial cells. Urinary podocalyxin is used as a marker for glomerular disease. However, there are no reports describing serum podocalyxin (s-Podxl) levels. Therefore, the association between s-Podxl levels and clinical parameters were examined with 52 patients. s-Podxl level was evaluated using enzyme-linked immunosorbent assay. The median s-Podxl level was 14.2\u2009ng\/dL (interquartile range: 10.8\u201322.2\u2009ng\/dL). There were significant correlations (correlation coefficient: r\u2009&gt;\u20090.2) of s-Podxl levels with carotid intima media thickness (IMT) (r\u2009=\u20090.30, p\u2009=\u20090.0307). Multiple logistic regression analysis showed that s-Podxl levels remained significantly associated with carotid IMT\u2009&gt;\u20091\u2009mm (OR: 1.15; 95% CI 1.02\u20131.31, p\u2009=\u20090.026) after adjustments for traditional cardiovascular risk factors such as age, sex, current smoking status, hypertension, dyslipidemias, and diabetes. In conclusion, s-Podxl is independently associated with carotid IMT and might be used as a novel biomarker for cardiovascular disease.<\/jats:p>","DOI":"10.1038\/s41598-017-18647-6","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T10:21:39Z","timestamp":1515061299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Mayumi","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9599-2465","authenticated-orcid":false,"given":"Minoru","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoka","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Koshizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"18647_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 135, e146\u2013e603 (2017).","journal-title":"Circulation."},{"key":"18647_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1083\/jcb.98.4.1591","volume":"98","author":"D Kerjaschki","year":"1984","unstructured":"Kerjaschki, D., Sharkey, D. J. & Farquhar, M. G. Identification and characterization of podocalyxin\u2013the major sialoprotein of the renal glomerular epithelial cell. The Journal of cell biology. 98, 1591\u20131596 (1984).","journal-title":"The Journal of cell biology."},{"key":"18647_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1084\/jem.194.1.13","volume":"194","author":"R Doyonnas.","year":"2001","unstructured":"Doyonnas., R. et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. The Journal of experimental medicine. 194, 13\u201327 (2001).","journal-title":"The Journal of experimental medicine."},{"key":"18647_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI12539","volume":"108","author":"T Takeda","year":"2001","unstructured":"Takeda, T. et al. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. The Journal of clinical investigation. 108, 289\u2013301 (2001).","journal-title":"The Journal of clinical investigation."},{"key":"18647_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1083\/jcb.102.2.484","volume":"102","author":"R Horvat","year":"1986","unstructured":"Horvat, R. et al. Endothelial cell membranes contain podocalyxin\u2013the major sialoprotein of visceral glomerular epithelial cells. The Journal of cell biology. 102, 484\u2013491 (1986).","journal-title":"The Journal of cell biology."},{"key":"18647_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0002-9440(10)65328-X","volume":"154","author":"A Miettinen","year":"1999","unstructured":"Miettinen, A. et al. Podocalyxin in rat platelets and megakaryocytes. The American journal of pathology. 154, 813\u2013822 (1999).","journal-title":"The American journal of pathology."},{"key":"18647_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1365-2141.2004.04840.x","volume":"124","author":"L Kerosuo","year":"2004","unstructured":"Kerosuo, L. et al. Podocalyxin in human haematopoietic cells. British journal of haematology. 124, 809\u2013818 (2004).","journal-title":"British journal of haematology."},{"key":"18647_CR8","doi-asserted-by":"publisher","first-page":"e12003","DOI":"10.1371\/journal.pone.0012003","volume":"5","author":"N Vitureira","year":"2010","unstructured":"Vitureira, N. et al. Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation. PloS one. 5, e12003 (2010).","journal-title":"PloS one."},{"key":"18647_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000188509","volume":"69","author":"M Hara","year":"1995","unstructured":"Hara, M. et al. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron. 69, 397\u2013403 (1995).","journal-title":"Nephron."},{"key":"18647_CR10","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","volume":"55","author":"M Hara","year":"2012","unstructured":"Hara, M. et al. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia. 55, 2913\u20132919 (2012).","journal-title":"Diabetologia."},{"key":"18647_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/1354750X.2015.1118551","volume":"21","author":"M Shoji","year":"2016","unstructured":"Shoji, M. et al. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes. Biomarkers. 21, 164\u2013167 (2016).","journal-title":"Biomarkers."},{"key":"18647_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0021-9150(88)90176-1","volume":"70","author":"A Poli","year":"1988","unstructured":"Poli, A. et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 70, 253\u2013261 (1988).","journal-title":"Atherosclerosis."},{"key":"18647_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.HYP.19.6.717","volume":"19","author":"ML Bots","year":"1992","unstructured":"Bots, M. L. et al. Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension. 19, 717\u2013720 (1992).","journal-title":"Hypertension."},{"key":"18647_CR14","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis. Oncotarget., doi: 10.18632\/oncotarget.14199 (2016).","DOI":"10.18632\/oncotarget.14199"},{"key":"18647_CR15","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1091\/mbc.11.9.3219","volume":"11","author":"T Takeda","year":"2000","unstructured":"Takeda, T. et al. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Molecular biology of the cell. 11, 3219\u20133232 (2000).","journal-title":"Molecular biology of the cell."},{"key":"18647_CR16","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.yexcr.2008.03.009","volume":"314","author":"S Larrucea","year":"2008","unstructured":"Larrucea, S. et al. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Experimental cell research. 314, 2004\u20132015 (2008).","journal-title":"Experimental cell research."},{"key":"18647_CR17","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pone.0000237","volume":"2","author":"JS Nielsen","year":"2007","unstructured":"Nielsen, J. S. et al. The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PloS one. 2, e237 (2007).","journal-title":"PloS one."},{"key":"18647_CR18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1084\/jem.187.12.1965","volume":"187","author":"C Sassetti","year":"1998","unstructured":"Sassetti, C. et al. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. The Journal of experimental medicine. 187, 1965\u20131975 (1998).","journal-title":"The Journal of experimental medicine."},{"key":"18647_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbrc.2013.01.112","volume":"432","author":"D Fernandez","year":"2013","unstructured":"Fernandez, D. et al. Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42. Biochemical and biophysical research communications. 432, 302\u2013307 (2013).","journal-title":"Biochemical and biophysical research communications."},{"key":"18647_CR20","doi-asserted-by":"publisher","first-page":"15708","DOI":"10.1074\/jbc.272.25.15708","volume":"272","author":"DB Kershaw","year":"1997","unstructured":"Kershaw, D. B. et al. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. The Journal of biological chemistry. 272, 15708\u201315714 (1997).","journal-title":"The Journal of biological chemistry."},{"key":"18647_CR21","first-page":"357","volume":"37","author":"S Okubo","year":"1995","unstructured":"Okubo, S. A study of urinary podocalyxin in children with IgA nephropathy. Nihon Jinzo Gakkai shi. 37, 357\u2013365 (1995).","journal-title":"Nihon Jinzo Gakkai shi."},{"key":"18647_CR22","doi-asserted-by":"publisher","first-page":"e0163507","DOI":"10.1371\/journal.pone.0163507","volume":"11","author":"T Imaizumi","year":"2016","unstructured":"Imaizumi, T. et al. Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy. PloS one. 11, e0163507 (2016).","journal-title":"PloS one."},{"key":"18647_CR23","doi-asserted-by":"publisher","first-page":"e108881","DOI":"10.1371\/journal.pone.0108881","volume":"9","author":"EJ Debruin","year":"2014","unstructured":"Debruin, E. J. et al. Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion. PloS one. 9, e108881 (2014).","journal-title":"PloS one."},{"key":"18647_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejcb.2016.04.006","volume":"95","author":"A Horrillo","year":"2016","unstructured":"Horrillo, A. et al. Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells. European journal of cell biology. 95, 265\u2013276 (2016).","journal-title":"European journal of cell biology."},{"key":"18647_CR25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.humpath.2010.02.004","volume":"41","author":"M Hara","year":"2010","unstructured":"Hara, M. et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol. 41, 1265\u20131275 (2010).","journal-title":"Hum Pathol."},{"key":"18647_CR26","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby, P. Inflammation in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 32, 2045\u20132051 (2012).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology."},{"key":"18647_CR27","first-page":"439","volume":"29","author":"SS Bassuk","year":"2004","unstructured":"Bassuk, S. S., Rifai, N. & Ridker, P. M. High-sensitivity C-reactive protein: clinical importance. Current problems in cardiology. 29, 439\u2013493 (2004).","journal-title":"Current problems in cardiology."},{"key":"18647_CR28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","volume":"367","author":"S Kaptoge","year":"2012","unstructured":"Kaptoge, S. et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 367, 1310\u20131320 (2012).","journal-title":"N Engl J Med."},{"key":"18647_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","volume":"123","author":"LB Daniels","year":"2011","unstructured":"Daniels, L. B. et al. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation. 123, 2101\u20132110 (2011).","journal-title":"Circulation."},{"key":"18647_CR30","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","volume":"286","author":"R Zhang","year":"2001","unstructured":"Zhang, R. et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 286, 2136\u20132142 (2001).","journal-title":"JAMA."},{"key":"18647_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.matbio.2015.01.015","volume":"44\u201346","author":"AC Newby","year":"2015","unstructured":"Newby, A. C. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation. Matrix Biol. 44\u201346, 157\u2013166 (2015).","journal-title":"Matrix Biol."},{"key":"18647_CR32","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","volume":"343","author":"CJ Packard","year":"2000","unstructured":"Packard, C. J. et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 343, 1148\u20131155 (2000).","journal-title":"N Engl J Med."},{"key":"18647_CR33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa022600","volume":"348","author":"C Heeschen","year":"2003","unstructured":"Heeschen, C. et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 348, 1104\u20131111 (2003).","journal-title":"N Engl J Med."},{"key":"18647_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","volume":"25","author":"AA House","year":"2010","unstructured":"House, A. A. et al. Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 25, 1416\u20131420 (2010).","journal-title":"Nephrol Dial Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18647-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:52:52Z","timestamp":1671846772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18647-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18647"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18647-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"4 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"245"}}